TAK-341
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAK-341, covering 2025-08-24 to 2026-06-02. Get the full timeline:
Most recent: Clinical Trial Results: A Study of TAK-341 in Treatment of Multiple System Atrophy [Phase 2]